ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Retransplantation"

  • 2020 American Transplant Congress

    Donor-Derived Cell-Free DNA May Not Discriminate Rejection in Kidney Transplant Recipients with a Prior Allograft in Place

    A. Vo, M. Gillespie, S. C. Jordan, A. Peng, R. Najjar, S. Sethi, K. Lim, N. Ammerman, E. Huang

    Cedars-Sinai, Los Angeles, CA

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) is an injury biomarker discriminating rejection in kidney transplant (KTx) patients (pts). However, its performance when stratified by rejection risk…
  • 2020 American Transplant Congress

    Re-Transplantation Outcomes in the United States Before and after DAA-Introduction

    T. Ivanics, M. Rizzari, A. Al-Kurd, T. Kitajima, A. Elsabbagh, K. Collins, A. Yoshida, M. Abouljoud, S. Nagai

    Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: The success of direct-acting antiviral (DAA) therapy has led to the widespread treatment of HCV and near-universal cure for chronically infected patients and improved…
  • 2020 American Transplant Congress

    Impact of Allograft Nephrectomy on Outcomes in Second Kidney Transplantation

    N. Sato, Y. Kakuta, T. Kanzawa, K. Unagami, M. Okumi, H. Ishida, K. Tanabe

    Urology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan

    *Purpose: The impact of failed allograft nephrectomy on the outcome of second kidney transplantation is not clear. We evaluated the effects of the first allograft…
  • 2020 American Transplant Congress

    Perioperative Extracorporeal Membrane Oxygenation (ECMO) in Liver Transplantation: A Case Series

    J. G. Guorgui1, T. Ito1, M. M. Lu1, P. Benharash2, A. Ardehali3, V. Gudzenko4, C. Wray4, V. G. Agopian1, J. DiNorcia III1, H. Yersiz1, D. G. Farmer1, R. W. Busuttil1, F. M. Kaldas1

    1The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, 2Cardiovascular Outcomes Research Laboratories, UCLA, Los Angeles, CA, 3Division of Cardiac Surgery, Department of Surgery, UCLA, Los Angeles, CA, 4Department of Anesthesiology, UCLA, Los Angeles, CA

    *Purpose: Extracorporeal Membrane Oxygenation (ECMO) is a life-saving treatment modality for patients who develop cardiopulmonary failure refractory to conventional efforts. ECMO has been used sparingly…
  • 2020 American Transplant Congress

    Intestinal Retransplantation: Survival Outcomes Similar to Primary Transplantation

    C. Beyersdorf, L. Vargas, D. Mercer, W. Grant, A. Langnas, S. Merani

    University of Nebraska Medical Center, Omaha, NE

    *Purpose: Isolated and multivisceral intestinal transplantation is indicated for patients with life threatening complications of intestinal failure. Intestinal retransplantation has been performed in select intestinal…
  • 2020 American Transplant Congress

    Effect of Maintaining Immunosuppression after Kidney Graft Failure on Mortality and Re-Transplantation

    C. Schinstock, S. Balakrishnan, A. Bentall, M. Merzkani, M. Stegall

    Mayo Clinic, Rochester, MN

    *Purpose: Patients with a failed renal allograft are at high risk for mortality. The potential benefit of maintaining immunosuppression with the intent to minimize sensitization…
  • 2020 American Transplant Congress

    Liver Retransplantation (reLT) in the Modern Post-MELD, Post-DAA Era

    B. Shi, C. Freise, D. Brandman

    School of Medicine, UCSF, San Francisco, CA

    *Purpose: Liver retransplantation (reLT) is responsible for a small proportion of all liver transplants (LT), but outcomes are much worse than primary LT. Hepatitis C…
  • 2020 American Transplant Congress

    Outcomes of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders: An Analysis of the UNOS/OPTN Database (1998 to 2019)

    W. Cheungpasitporn1, C. Thongprayoon2, C. C. Jadlowiec3, W. J. Chon4, L. S. Cummings4, S. R. Katari4, N. Leeaphorn4

    1Nephrology, University of Mississippi Medical Center, Jackson, MS, 2Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 3Transplant Surgery, Mayo Clinic, Phoenix, AZ, 4Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO

    *Purpose: Post-transplant lymphoproliferative disease (PTLD) is a serious, potentially fatal complication after kidney transplantation. Existing literature on outcomes of kidney retransplantation in patients with prior…
  • 2020 American Transplant Congress

    Impact of Donation after Circulatory Death Allografts on Outcomes Following Liver Re-Transplantation in the United States

    S. Kumar1, S. Lin2, J. D. Schold2

    1Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 2Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of donation after circulatory death (DCD) donors. Complications following LT and disease recurrence…
  • 2020 American Transplant Congress

    Alemtuzumab and Associated Infectious and Transplant Outcomes in Renal Re-Transplant Patients

    T. N. Harris

    The Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC

    *Purpose: The purpose of this study was to evaluate infectious and transplant outcomes exclusively in renal re-transplant patients who had received alemtuzumab for induction therapy.*Methods:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences